Category Archives: Hepatitis C care & treatment

Vosevi: Frequently Asked Questions

On July 18, 2017 the Food and Drug Administration (FDA) approved Gilead’s HCV medication sofosbuvir/velpatasvir/voxilaprevir (400mg/100mg/100mg), brand name “Vosevi” for the re-treatment of HCV in treatment-experienced people. This single tablet medication comprises sofosbuvir (SOF), a nucleotide polymerase inhibitor, velpatasvir (VEL), an NS5A inhibitor, and voxilaprevir (VOX),…Read More

Project Inform releases new report on safer consumption spaces in the U.S.

SAFER CONSUMPTION SPACES IN THE UNITED STATES: The time is right to unite for a national movement Click here for a PDF of the Report. Project Inform is pleased to release “Safer Consumption Spaces in the United States: Uniting for a National Movement.” This report stems…Read More

Working at the State Level: Project Inform’s California Advocacy for 2017

State-level advocacy efforts are crucial to create lasting change. Often efforts that are started at local and state levels inform national trends and structural changes at the federal level (think about the history of same-sex marriage, health care reform, and syringe exchange in the United States)….Read More

CROI 2017: New two-drug maintenance regimen continues to suppress HIV over 144 weeks

At the 2017 Conference on Retroviruses and Opportunistic Infections (CROI), results from the LATTE study showed that the 2-drug regimen of the integrase inhibitor cabotegravir (CAB) + the NNRTI rilpirivine (RPV, Edurant) suppressed HIV levels as well as a 3-drug efavirenz (Sustiva) regimen through 144 weeks….Read More

CROI 2017: Ibalizumab is effective at reducing HIV viral load in people with few treatment options

In a late-breaker presentation at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI), a new monoclonal antibody drug called ibalizumab reduced viral loads in individuals with multi-drug resistant HIV. The results showed that adding the drug to a failing regimen may help treatment-experienced people who…Read More

Statement from Covered California’s Peter V. Lee on the House Passage of the American Health Care Act

SACRAMENTO, CA. — Covered California Executive Director Peter V. Lee released the following statement on the passing of the American Health Care Act by the U.S. House of Representatives: “Today the House of Representatives took a significant step toward making what could be monumental changes to…Read More

Project Inform releases new baby boomer videos on hepatitis C treatment

At least 3.5 million Americans are living with HCV, though it’s likely that there are many more. Approximately three-fourths of this group were born between 1945 and 1965 — the baby boomer generation. Since hepatitis C disease usually has no symptoms early on, about half of those…Read More